![]() |
Volumn 2, Issue 9, 2001, Pages 771-773
|
Pathogenesis of arthritis: Recent research progress
|
Author keywords
[No Author keywords available]
|
Indexed keywords
APOLIPOPROTEIN A1;
C REACTIVE PROTEIN;
CD4 ANTIGEN;
COLLAGEN TYPE 2;
CYCLOOXYGENASE 2;
CYTOKINE;
EPITOPE;
ETANERCEPT;
GLUCOSE 6 PHOSPHATE ISOMERASE;
HLA ANTIGEN CLASS 2;
HLA B27 ANTIGEN;
HLA DR ANTIGEN;
IMMUNOGLOBULIN ENHANCER BINDING PROTEIN;
INFLIXIMAB;
INTERLEUKIN 1 RECEPTOR;
INTERLEUKIN 18;
INTERLEUKIN 1BETA;
INTERLEUKIN 6;
LYMPHOCYTE ANTIGEN;
METALLOPROTEINASE;
MITOGEN ACTIVATED PROTEIN KINASE;
TUMOR NECROSIS FACTOR;
ANIMAL MODEL;
APOPTOSIS;
ARTICLE;
AUTOIMMUNE DISEASE;
CONTROLLED STUDY;
GENE DELIVERY SYSTEM;
GENE THERAPY;
HUMAN;
IMMUNE RESPONSE;
LYMPHOCYTE FUNCTION;
LYMPHOCYTIC INFILTRATION;
MACROPHAGE;
MAJOR HISTOCOMPATIBILITY COMPLEX;
MOUSE;
NONHUMAN;
PHENOTYPE;
PREVALENCE;
PRIORITY JOURNAL;
REMISSION;
RHEUMATOID ARTHRITIS;
T LYMPHOCYTE;
TISSUE INJURY;
TREATMENT OUTCOME;
ARTHRITIS, RHEUMATOID;
CYTOKINES;
DISEASE PROGRESSION;
GENES, MHC CLASS II;
GENETIC PREDISPOSITION TO DISEASE;
HUMANS;
MODELS, IMMUNOLOGICAL;
T-LYMPHOCYTES;
TUMOR NECROSIS FACTOR-ALPHA;
|
EID: 0035555275
PISSN: 15292908
EISSN: None
Source Type: Journal
DOI: 10.1038/ni0901-771 Document Type: Article |
Times cited : (135)
|
References (18)
|